RESUMO
INTRODUCTION: Blepharospasm (BSP) represents one of the most common idiopathic adult-onset dystonia. A few longitudinal observations indicated progression and worsening of BSP severity within 16 years of onset. Information is lacking about the trend of BSP severity in the later stages of the disease. METHODS: The study comprised 15 women and 3 men that underwent a standardized video protocol at two time points: 14 ± 9 years after BSP onset and 11 ± 2 years later. BSP severity was rated by the Blepharospasm Severity Rating Scale (BSRS). Two independent observers reviewed 36 videos in a pseudo-randomized order, yielding satisfactory agreement. RESULTS: Mean total severity score was 7.6 ± 3.9 years at baseline, 6.4 ± 2.5 at the last examination (p = 0.14). The last video examination showed a stable BSRS score in 14/18 patients, while the score of 4 patients decreased by two points or more, due to disappearance (n.3) or reduction (n.1) of prolonged spasms with complete rim closure. Over the long term, the BoNT dosage increased in those who improved, but remained stable in the other patients. On follow-up examination, dystonia spread to the lower face or neck in two new patients. No significant correlations emerged between disease duration and BSP severity. The presence of sensory trick significantly correlated with disease duration but not with BSP severity. DISCUSSION: This study provides novel information on the long-term prognosis in patients with idiopathic BSP, showing that severity of BSP may not worsen in the later stages of the disease.
Assuntos
Blefarospasmo , Progressão da Doença , Índice de Gravidade de Doença , Humanos , Blefarospasmo/fisiopatologia , Masculino , Feminino , Pessoa de Meia-Idade , Estudos Longitudinais , Idoso , AdultoRESUMO
BACKGROUND: Several earlier studies showed a female predominance in idiopathic adult-onset dystonia (IAOD) affecting the craniocervical area and a male preponderance in limb dystonia. However, sex-related differences may result from bias inherent to study design. Moreover, information is lacking on whether sex-related differences exist in expressing other dystonia-associated features and dystonia spread. OBJECTIVE: To provide accurate information on the relationship between sex differences, motor phenomenology, dystonia-associated features and the natural history of IAOD. METHODS: Data of 1701 patients with IAOD from the Italian Dystonia Registry were analysed. RESULTS: Women predominated over men in blepharospasm, oromandibular, laryngeal and cervical dystonia; the sex ratio was reversed in task-specific upper limb dystonia; and no clear sex difference emerged in non-task-specific upper limb dystonia and lower limb dystonia. This pattern was present at disease onset and the last examination. Women and men did not significantly differ for several dystonia-associated features and tendency to spread. In women and men, the absolute number of individuals who developed dystonia tended to increase from 20 to 60 years and then declined. However, when we stratified by site of dystonia onset, different patterns of female-to-male ratio over time could be observed in the various forms of dystonia. CONCLUSIONS: Our findings provide novel evidence on sex as a key mediator of IAOD phenotype at disease onset. Age-related sexual dimorphism may result from the varying exposures to specific age-related and sex-related environmental risk factors interacting in a complex manner with biological factors such as hormonal sex factors.
Assuntos
Idade de Início , Distúrbios Distônicos , Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Adulto , Distúrbios Distônicos/fisiopatologia , Idoso , Fatores Sexuais , Sistema de Registros , Itália , Adulto Jovem , Distonia/fisiopatologia , Blefarospasmo/fisiopatologia , Progressão da DoençaRESUMO
Blepharospasm is a common form of focal dystonia characterized by excessive and involuntary spasms of the orbicularis oculi. In addition to idiopathic blepharospasm, lesions in various brain regions can also cause acquired blepharospasm. Whether these two types of blepharospasm share a common brain network remains largely unknown. Herein, we performed lesion coactivation network mapping, based on meta-analytic connectivity modeling, to test whether lesions causing blepharospasm could be mapped to a common coactivation brain network. We then tested the abnormality of the network in patients with idiopathic blepharospasm (n = 42) compared with healthy controls (n = 44). We identified 21 cases of lesion-induced blepharospasms through a systematic literature search. Although these lesions were heterogeneous, they were part of a co-activated brain network that mainly included the bilateral supplementary motor areas. Coactivation of these regions defines a single brain network that encompasses or is adjacent to most heterogeneous lesions causing blepharospasm. Moreover, the bilateral supplementary motor area is primarily associated with action execution, visual motion, and imagination, and participates in finger tapping and saccades. They also reported decreased functional connectivity with the left posterior cingulate cortex in patients with idiopathic blepharospasm. These results demonstrate a common convergent abnormality of the supplementary motor area across idiopathic and acquired blepharospasms, providing additional evidence that the supplementary motor area is an important brain region that is pathologically impaired in patients with blepharospasm.
Assuntos
Blefarospasmo , Córtex Motor , Humanos , Blefarospasmo/fisiopatologia , Blefarospasmo/etiologia , Feminino , Córtex Motor/fisiopatologia , Córtex Motor/diagnóstico por imagem , Masculino , Idoso , Pessoa de Meia-Idade , Imageamento por Ressonância Magnética , Rede Nervosa/fisiopatologia , Rede Nervosa/diagnóstico por imagemRESUMO
ABSTRACT Objective: To determine whether serum levels of anti-acetylcholine receptor antibody (anti-AChR-Abs) are related to clinical parameters of blepharospasm (BSP). Methods: Eighty-three adults with BSP, 60 outpatients with hemifacial spasm (HFS) and 58 controls were recruited. Personal history, demographic factors, response to botulinum toxin type A (BoNT-A) and other neurological conditions were recorded. Anti-AChR-Abs levels were quantified using an enzyme-linked immunosorbent assay. Results: The anti-AChR Abs levels were 0.237 ± 0.022 optical density units in the BSP group, which was significantly different from the HFS group (0.160 ± 0.064) and control group (0.126 ± 0.038). The anti-AChR Abs level was correlated with age and the duration of response to the BoNT-A injection. Conclusion: Patients with BSP had an elevated anti-AChR Abs titer, which suggests that dysimmunity plays a role in the onset of BSP. An increased anti-AChR Abs titer may be a predictor for poor response to BoNT-A in BSP.
RESUMO Objetivo: Determinar se os níveis séricos do anticorpo antirreceptor de acetilcolina (anti-AChR-Abs) estão relacionados aos parâmetros clínicos do blefaroespasmo (BSP). Métodos: Fora recrutados 83 adultos com BSP, 60 pacientes ambulatoriais com espasmo hemifacial (HFS) e 58 controles. Foi aplicado um questionário para registrar história pessoal, fatores demográficos, resposta à toxina botulínica tipo A (BoNT-A) e outras condições neurológicas. Os níveis de anti-AChR-Abs foram quantificados usando um ensaio imunoenzimático. Resultados: O nível de anti-AChR-Abs foi de 0,237 ± 0,022 unidades de densidade óptica (OD) no grupo BSP, significativamente diferente em comparação com o grupo HFS (0,160 ± 0,064) e o grupo controle (0,126 ± 0,038). O nível de anti-AChR-Abs se correlacionou com a idade e a duração da resposta à injeção de BoNT-A. Conclusão: Pacientes com BSP apresentaram títulos elevados de anti-AChR-Abs, o que sugere que a desimunidade desempenha um papel no surgimento de BSP. O aumento do título de anti-AChR-Abs pode ser um preditor de resposta insuficiente à BoNT-A em BSP.
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Autoanticorpos/sangue , Blefarospasmo/sangue , Receptores Colinérgicos/imunologia , Espasmo Hemifacial/sangue , Valores de Referência , Blefarospasmo/fisiopatologia , Blefarospasmo/tratamento farmacológico , Ensaio de Imunoadsorção Enzimática , Estudos de Casos e Controles , Fatores Sexuais , Análise de Variância , Fatores Etários , Toxinas Botulínicas Tipo A/uso terapêutico , Espasmo Hemifacial/fisiopatologia , Espasmo Hemifacial/tratamento farmacológico , Eletromiografia , Fármacos Neuromusculares/uso terapêuticoRESUMO
Introducción. El parpadeo es un movimiento habitualmente espontáneo, consecuencia de la actividad alternante y antagónica de los músculos orbicularis oculi y levator palpebrae superioris. Para conseguir un movimiento eficiente se regulan por inhibición recíproca de tal modo que el movimiento agonista provoca la inhibición simultánea del antagonista, y viceversa. La cocontracción es la disfunción de este mecanismo, y constituye un fenómeno relevante en trastornos distónicos, en especial en movimientos simples no sujetos a variabilidad como el parpadeo. El blefaroespasmo es la distonía más frecuente del adulto y su diagnóstico es sencillo. En procesos incipientes puede presentar dificultades e incluso confundirse con otros procesos. Evaluamos la posibilidad de diagnóstico precoz de blefaroespasmo en pacientes con hiperfunción palpebral de poco tiempo de evolución. Pacientes y métodos. Hemos evaluado prospectivamente a 23 pacientes con sospecha de blefaroespasmo. Se les realizó un estudio electromiográfico simultáneo de los músculos orbicularis oculi y levator palpebrae. Resultados. La presencia de cocontracción en alguno de los parpadeos registrados se relacionó con el desarrollo o no de blefaroespasmo en los años siguientes. Ningún paciente sin parpadeos distónicos presentó blefaroespasmo en los años del seguimiento; por el contrario, todos los que presentaron alguno lo desarrollaron. Conclusiones. Hemos obtenido parpadeos distónicos en todos los pacientes que desarrollaron blefaroespasmo, y los parpadeos fueron fisiológicos en aquellos que no lo presentaron. La evaluación electromiográfica simultánea de la musculatura palpebral es una exploración sencilla, sensible, bien tolerada y especialmente específica para determinar si se desarrollará blefaroespasmo en un momento evolutivo temprano (AU)
Introduction. Blinking is usually a spontaneous movement that takes place as a consequence of the alternating and antagonistic activity of the orbicularis oculi and levator palpebrae superioris muscles. In order to achieve an efficient movement, they are regulated by a reciprocal inhibition in such a way that the agonistic movement triggers the simultaneous inhibition of the antagonist, and vice-versa. Co-contraction is the dysfunction of this mechanism and is a significant phenomenon in dystonic disorders, especially in simple movements that are not subject to variability, as is the case of blinking. Blepharospasm is the most frequent dystonia affecting adults and it is easy to diagnose. In incipient processes it may offer some difficulties and can even be mistaken for other processes. We evaluate the possibility of an early diagnosis of blepharospasm in patients with palpebral hyperfunction with a short time to progression. Patients and methods. A prospective evaluation of 23 patients with suspected blepharospasm was conducted. Each of them was submitted to a simultaneous electromyographic study of the orbicularis oculi and levator palpebrae muscles. Results. The presence of co-contraction in any of the blinking movements recorded was related with the chances of developing blepharospasm in the following years. None of the patients who did not have dystonic blinking presented blepharospasm in the years of the follow-up; in contrast, it was developed by all of those who presented it on some occasion. Conclusions. Dystonic blinking was observed in all the patients with blepharospasm, and blinking was physiological in those who did not present it. Simultaneous electromyographic evaluation of the muscles of the eyelids is a simple, sensitive, well-tolerated and particularly specific examination that can be used to determine whether a patient will show blepharospasm in an early stage of development (AU)
Assuntos
Humanos , Eletromiografia/métodos , Blefarospasmo/fisiopatologia , Músculos Faciais/fisiopatologia , Estudos Prospectivos , Distonia/fisiopatologia , Piscadela/fisiologia , Transtornos dos Movimentos/fisiopatologia , Fatores de RiscoRESUMO
OBJETIVO: Avaliar as aberrações ópticas de alta ordem em pacientes com distonias faciais tratados com toxina botulínica tipo A. MÉTODOS: Pacientes com diagnóstico clínico de espasmo hemifacial ou blefaroespasmo essencial em atividade foram submetidos ao exame biomicroscópico e à análise de frente de ondas através do aberrômetro Alcon LADARvision®, sob midríase medicamentosa. A seguir, foram tratados com injeções de toxina botulínica tipo A. Após um mês, a análise de frente de ondas foi repetida da mesma forma e pelo mesmo oftalmologista. As aberrações de alta ordem foram comparadas antes e após o tratamento. O teste T pareado foi utilizado para comparar os valores numéricos antes e após o tratamento. RESULTADOS: Foram incluídos no estudo um total de 11 pacientes, 6 com blefaroespasmo essencial (54,5 por cento) e 5 com espasmo hemifacial (45,5 por cento). Nos pacientes com espasmo hemifacial foram analisados apenas o lado acometido, totalizando 17 olhos com espasmo. A idade variou de 50 a 72 anos, com média de 65,9 ± 8,2 anos. Oito pacientes eram do sexo feminino (72,7 por cento), sendo a relação masculino/feminino de 1:2,6. A média do "root mean square" (RMS) das aberrações de alta ordem foi 0,68 antes e 0,63 após um mês do tratamento (p=0,01). A média da aberração esférica foi de 0,23 e 0,17 antes e após o tratamento respectivamente (p=0,01). Não houve diferenças estatisticamente significantes nos demais tipos de aberrações de alta ordem após o tratamento (p>0,05). CONCLUSÃO: O tratamento com toxina botulínica A pode diminuir as aberrações esféricas em pacientes com distonias faciais.
PURPOSE: To analyze the ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin A. METHODS: Patients with benign essential blepharospasm and hemifacial spasm in activity underwent slit lamp examination and bilateral wavefront analysis under pharmacologic mydriasis using Alcon LADARvision® wavefront aberrometry system. After that, all patients were treated with botulinum toxin A injections performed by the same ophthalmologist. After one month, the wavefront analysis was performed in the same way and by the same examiner. The main outcome measure was the change in ocular wavefront aberrations. Paired T-test was used to compare pre and post-injection numeric wavefront values. RESULTS: From a total of 11 patients enrolled in this study, 6 (54.5 percent) had essential blepharospasm and 5 (45.5 percent) had hemifacial spasm. The fellow eyes of patients with hemifacial spasm were not included, totalizing 17 eyes with spasm. Eight patients were female (72.7 percent) and three were male (27.3 percent), the male:female ratio was 1:2.6. The age ranged from 50 to 72 years old with a mean of 65.9 ± 8.2 years. The mean of high order root mean square (RMS) wavefront aberrations was 0.68 before and 0.63 one month after the treatment (p=0.01). Before the treatment, the mean of spherical aberration was 0.23 and decreased to 0.17 one month after the treatment (p=0.01). There was no significant difference in the other higher-order aberrations before and after the treatment (p>0.05). CONCLUSION: The treatment with botulium toxin may decrease spherical aberrations in patients with facial dystonia.
Assuntos
Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Blefarospasmo/tratamento farmacológico , Toxinas Botulínicas Tipo A/uso terapêutico , Aberrações de Frente de Onda da Córnea/tratamento farmacológico , Distonia/tratamento farmacológico , Espasmo Hemifacial/tratamento farmacológico , Fármacos Neuromusculares/uso terapêutico , Blefarospasmo/fisiopatologia , Distonia/fisiopatologia , Espasmo Hemifacial/fisiopatologia , Resultado do TratamentoRESUMO
BACKGROUND: Non-motor symptoms have been described in primary dystonia, but the results on cognitive impairment in this condition are discordant. Blepharospasm (BM) is a type of primary focal dystonia characterized by recurrent and involuntary eye blinking. Hemifacial spasm (HS), a condition with different pathophysiology, constitutes an adequate control group when investigating non-motor disturbances in BM. OBJECTIVE:To compare the performance of patients with BM and HS in the Frontal Assessment Battery (FAB). METHOD: Twenty-two patients with BM and 29 patients with HS were submitted to the FAB and the Mini-Mental State Examination (MMSE). FAB scores were compared between the two groups. Correlations between FAB and sociodemographic and clinical variables were calculated. RESULTS: BM group was not different from HS in relation to gender, age, length of symptoms, educational level and performance in the MMSE. FAB scores were also similar in both groups. FAB scores correlated negatively with age and positively with educational level and MMSE scores. CONCLUSION: Executive functioning as assessed by FAB is not altered in BM in comparison with HS.
INTRODUÇÃO: Alterações não-motoras são descritas na distonia primária, embora sejam conflitantes os resultados sobre prejuízo cognitivo nessa condição. Blefaroespasmo (BE) é um tipo de distonia primária focal caracterizada por contrações recorrentes e involuntárias das pálpebras. Espasmo hemifacial (EH), cuja fisiopatologia é distinta do BE, constitui bom grupo controle quando se investiga alterações não-motoras no BE. OBJETIVO: Comparar o desempenho de pacientes com BE e com EH na Bateria de Avaliação Frontal (BAF). MÉTODO: BAF e Mini-Exame do Estado Mental (MEEM) foram administrados a 22 pacientes com BE e 29 com EH. Os escores da BAF foram comparados entre os dois grupos. Correlações entre resultados na BAF e variáveis sócio-demográficas e clínicas foram calculadas. RESULTADOS: Os grupos BE e EH foram semelhantes quanto a gênero, idade, duração dos sintomas, escolaridade e desempenho no MEEM. Os escores dos dois grupos na BAF foram também similares, correlacionando-se negativamente com idade e positivamente com escolaridade e desempenho no MEEM. CONCLUSÃO: As funções executivas avaliadas pela BAF não estão alteradas no BE em relação ao EH.
Assuntos
Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Blefarospasmo/fisiopatologia , Função Executiva , Lobo Frontal/fisiopatologia , Espasmo Hemifacial/fisiopatologia , Blefarospasmo/psicologia , Demência/fisiopatologia , Distonia/fisiopatologia , Distonia/psicologia , Espasmo Hemifacial/psicologia , Testes Neuropsicológicos , Estatísticas não ParamétricasRESUMO
El blefaroespasmo esencial benigno cursa con movimientos repetitivos anormales del cierre de los párpados y espasmo del músculo orbicular de los ojos. Modernas teorías postulan que este trastorno del movimiento se origina por alteraciones en el procesamiento de la información aferente, con posterior desintegración de dicha información a nivel del programa neural sensorimotor que existe en el sistema nervioso central, que se manifiesta luego como movimiento anormal en los individuos genéticamente susceptibles. Diferentes investigaciones que incluyen estudios imagenológicos, genéticos y neurofisiológicos han proporcionado nuevos hallazgos acerca de las áreas neurales involucradas en esta patología y la forma como se genera este trastorno. Dentro de estas investigaciones sobresale el estudio del reflejo del parpadeo obtenido eléctricamente, el cual consta de tres respuestas llamadas no-nociceptiva (R1), nociceptiva (R2) y ultranociceptiva (R3). Dicho reflejo y, principalmente, la respuesta refleja ultranociceptiva (R3) parece ser muy útil para entender más profundamente la fisiopatología de esta distonía focal y realizar la endofenotipificación funcional y seguimiento en la neuro rehabilitación correspondiente de este complejo problema neurológico.
Benign essential blepharospasm is characterized by abnormal repetitive movements of lid closure and spasm of the orbiculari oculi muscles. Modern theories postulate that this movement disorder originates by abnormal processing of afferent information with further disintegration of the sensorimotor neural program at central levels of the nervous system all of which is seen as dystonic movements in genetically susceptible people. Different investigations including neuroimagin, genetic and neurophysiological studies have discovered new findings on what structures are involved and how this abnormal movement is generated. Among these research is noteworthy the study of electrically elicited blink reflex. It consists of three responses called non-nociceptive (R1), nociceptive (R2) and ultranociceptive (R3). Such blink reflexes, mostly the ultranociceptive response (R3), seem to be very useful to understand more deeply the pathophysiology of this focal dystonia, to perform the functional endophenotyping and to do a more appropriate follow-up of this complex neurological problem.
Assuntos
Humanos , Blefarospasmo/fisiopatologia , Piscadela/fisiologia , Espasmo Hemifacial/fisiopatologia , Blefarospasmo/genética , Aparelho Lacrimal/fisiopatologiaRESUMO
OBJETIVO: Avaliar os custos do tratamento para blefaroespasmo essencial e espasmo hemifacial com toxina botulínica tipo A (Dysport®), correlacionando-os com sua eficácia terapêutica. MÉTODOS: Análise de 50 prontuários de pacientes com blefaroespasmo essencial e espasmo hemifacial, submetidos à terapia com Dysport®, no período de abril de 2002 a maio de 2004 no setor de Oculo-Plástica da Santa Casa de São Paulo. Dos 50 pacientes, 27 apresentavam blefaroespasmo essencial e 23 espasmo hemifacial. Informações sobre grau de satisfação, queixas e custos pessoais foram obtidas mediante questionário. Os custos do medicamento e dos materiais foram pesquisados no almoxarifado e na farmácia da Santa Casa. Quanto ao custo das consultas, utilizou-se a tabela de pagamento do SUS. Para a estatística foram utilizados os testes de Wilcoxon e Mann-Whitney. RESULTADOS: O custo total anual do tratamento foi de R$ 1.239,32 para o blefaroespasmo essencial e R$ 661,72 para o espasmo hemifacial. Para o paciente, o custo anual foi de R$ 145,48 para o blefaroespasmo essencial e R$ 126,07 para o espasmo hemifacial. Para o hospital, o custo anual foi de R$ 1.095,84 para o blefaroespasmo essencial e R$ 535,65 para o espasmo hemifacial. O tratamento com Dysport® promoveu melhora funcional significativa nos dois grupos. CONCLUSÃO: O procedimento tem custo elevado, principalmente devido ao preço da toxina. Entretanto, pela análise econômica da saúde fica demonstrado que o procedimento possui excelente relação custo-benefício.
PURPOSE: To evaluate the costs and efficacy of type A botulinum toxin in the treatment of essential blepharospasm and hemifacial spasm. METHODS: Pacients with essential blepharospasm and hemifacial spasm had their files analyzed. All patients were treated with type A botulinum toxin (Dysport®) between April 2002 and May 2004 at the Oculoplastic Clinics of "Santa Casa de São Paulo". Twenty-seven patients presented essential blepharospasm and 23 presented hemifacial spasm. Information about the patient's degree of satisfaction after treatment, complaints and personal costs were recorded by a questionnaire, and information about the costs of Dysport® treatment were obtained at the administration department of "Santa Casa de São Paulo". Wilcoxon and Mann-Whitney tests were used for statistical analysis. RESULTS: 1- The annual treatment costs were R$ 1,239.32 for essential blepharospasm and R$ 661.72 for hemifacial spasm. 2- The patient's annual costs were R$ 145.48 for essential blepharospasm and R$ 6.07 for hemifacial spasm. 3- The hospital's annual costs for the treatment were R$ 1,095.84 for essential blepharospasm and R$ 535.65 for hemifacial spasm. 4- Dysport® treatment is successful in both essential blepharospasm and hemifacial spasm. CONCLUSIONS:. The costs of essential blepharospasm and hemifacial spasm treatment with Dysport® are high, mainly because of the toxin price. On economic analysis of health, we can conclude that this procedure has an excellent cost-benefit ratio.